Nordea Investment Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Nordea Investment Management's NVAX Position: Q2 2022 in Review
Nordea Investment Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 4,000 shares — an estimated $300K sold.
Nordea Investment Management first reported a position in NVAX in Q4 2020 and held it in 6 quarters. The position peaked at $10.6M in Q1 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- Nordea Investment Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- Nordea Investment Management sold 4,000 Novavax shares in Q2 2022, an estimated $300K.
- Nordea Investment Management first reported a position in Novavax in Q4 2020 and held it in 6 quarters.
- Nordea Investment Management's Novavax position peaked at $10.6M in Q1 2021.
- 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on Nordea Investment Management's 13F filing for Q2 2022, filed 9 Aug 2022.